CSS LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,276
| Closed | -$3.73M | – | 1155 |
|
|
2023
Q3 | $3.73M | Buy |
32,276
+23,300
| +260% | +$2.5M | 0.31% | 77 |
|
|
2023
Q2 | $923K | Buy |
8,976
+5,500
| +158% | +$580K | 0.07% | 243 |
|
|
2023
Q1 | $379K | Sell |
3,476
-24
| -0.7% | -$2.65K | 0.03% | 399 |
|
|
2022
Q4 | $398K | Buy |
+3,500
| New | +$291K | 0.03% | 439 |
|
|
2021
Q1 | – | Sell |
-3,686
| Closed | -$269K | – | 1347 |
|
|
2020
Q4 | $269K | Sell |
3,686
-103,576
| -97% | -$7.7M | 0.02% | 585 |
|
|
2020
Q3 | $8.33M | Buy |
107,262
+1,500
| +1% | +$103K | 0.62% | 49 |
|
|
2020
Q2 | $5.88M | Buy |
+105,762
| New | +$4.52M | 0.49% | 76 |
|
|
2019
Q1 | – | Sell |
-406
| Closed | -$9.62K | – | 681 |
|
|
2018
Q4 | $8K | Buy |
+406
| New | +$7.96K | ﹤0.01% | 521 |
|
|
2018
Q1 | – | Sell |
-35,487
| Closed | -$524K | – | 717 |
|
|
2017
Q4 | $518K | Hold |
35,487
| – | – | 0.03% | 350 |
|
|
2017
Q3 | $450K | Buy |
35,487
+30,400
| +598% | +$387K | 0.03% | 373 |
|
|
2017
Q2 | $60K | Sell |
5,087
-36,200
| -88% | -$450K | ﹤0.01% | 590 |
|
|
2017
Q1 | $610K | Sell |
41,287
-29,173
| -41% | -$472K | 0.04% | 293 |
|
|
2016
Q4 | $1.14M | Buy |
70,460
+29,500
| +72% | +$535K | 0.08% | 225 |
|
|
2016
Q3 | $743K | Buy |
+40,960
| New | +$800K | 0.05% | 302 |
|
|
2016
Q1 | – | Sell |
-30,560
| Closed | -$535K | – | 823 |
|
|
2015
Q4 | $662K | Buy |
+30,560
| New | +$595K | 0.05% | 307 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB